Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults
AustriaStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
BelgiumStudy on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease
FranceStudy on the Effects of Ruxolitinib Cream for Patients with Genital Vitiligo
FranceStudy on Zetomipzomib for Patients with Active Lupus Nephritis
CroatiaStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
AustriaStudy on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus
FranceStudy on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes
BelgiumStudy on the Effectiveness and Safety of Phleum Pratense Pollen Extract for Patients with Moderate-to-Severe Grass Pollen Allergy
GermanyStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)
CzechiaStudy on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
